Depth Filter Clarification for Extracellular Vesicle Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying extracellular vesicles (EVs) are inadequate in removing impurities such as host cell proteins, DNA, and lipids, leading to heterogeneity and complexity that hinder their therapeutic use due to insufficient selectivity and scalability, making large-scale production challenging and costly.
Innovation Solution
The use of low aluminum (LA) and SP media grade depth filters for a depth filter-based clarification step prior to chromatography, which significantly reduces impurities and increases the dynamic binding capacity of chromatography resins, allowing for more efficient purification and recovery of EVs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional purification methods are used, then the process is simple, but the selectivity to remove impurities is insufficient
Solution Approach 1:
The purification process is divided into multiple sequential steps: depth filtration (using LA and SP filters), chromatography (using AEX and MMC columns), and ultrafiltration. Each step targets specific impurities, with depth filtration removing particulate matter and proteins, chromatography separating EVs from remaining contaminants based on charge and size, and ultrafiltration concentrating and final-purifying the EV preparation. This segmentation enables high purity while maintaining process manageability.
Solution Approach 2:
Depth filtration is performed as a preliminary step before chromatography to remove bulk impurities including host cell proteins, DNA, and particulate matter. This preliminary action reduces the load on subsequent chromatography columns, improving their efficiency and extending their service life, while ensuring that only purified material enters the final ultrafiltration step.
2Quantity of substance
If large-scale production is implemented, then the quantity of EVs increases, but the heterogeneity and variability increase
Solution Approach 1:
The process controls critical parameters including pH (maintained at 7.0-7.4), temperature (2-8°C), filtration pressure (0.1-1.0 MPa), and flow rates to ensure consistent EV preparation across large scales. The depth filtration step uses specific pore sizes (0.03-2.0 μm) and the chromatography columns are operated at controlled flow rates, all of which maintain homogeneity while enabling large-scale production.
Solution Approach 2:
Quality control measurements including nanoparticle tracking analysis (NTA), flow cytometry, and Western blotting are performed at each step to monitor EV purity, size distribution, and protein content. This feedback allows real-time adjustment of process parameters and ensures batch-to-batch consistency, enabling scalable production without sacrificing homogeneity.
3Manufacturing precision
If additional purification steps are added, then the purity of EVs improves, but the production cost increases
Solution Approach 1:
The depth filtration step extracts and removes the bulk of impurities including host cell proteins, DNA, and particulate matter before chromatography. This extraction approach is cost-effective because it handles the majority of contamination removal in a simple, scalable filtration process rather than requiring complex chromatography for all purification steps.
Solution Approach 2:
The process discards filtered impurities at the depth filtration step and recovers EVs through ultrafiltration concentration. The chromatography columns are regenerated and reused multiple times, reducing the need for continuous column replacement and lowering overall production costs while maintaining high purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in highly purified EVs with reduced impurities and improved recovery, enabling their therapeutic use by enhancing the purity and yield of EVs, particularly during large-scale production.
Implementation Method 1
contacting the sample with a depth filter selected from a low aluminum (LA) media grade depth filter, a SP media grade depth filter, or both
Data Source
AI summary
The present disclosure relates to methods for preparing extracellular vesicles (EVs). In particular, the methods provided herein comprise contacting a sample, which comprises EVs and one or more impurities, with a depth filter, wherein the depth filter is selected from a LA media grade depth filter, a SP media grade depth filter, or both. In some aspects, the methods further comprise one or more chromatography steps. The methods enable preparation of EVs for therapeutic and diagnostic applications, and isolation and/or sub-fractionation of EVs with desired properties for specific use.